Discovery and biological activity of computer-assisted drug designed Akt pathway inhibitors

Area of Science:

• Biochemistry
• Molecular Biology
• Oncology

Background:

• The phosphoinositide 3-kinase (PI3K)/Akt pathway is a critical regulator of cell growth and survival.
• Aberrant activation of the PI3K/Akt pathway is implicated in the pathogenesis of various human cancers.
• Targeting this pathway presents a promising strategy for cancer therapy.

Purpose of the Study:

• To identify and characterize novel inhibitors of the PI3K/Akt pathway.
• To evaluate the efficacy of these inhibitors in blocking Akt activation and neoplastic cell proliferation.

Main Methods:

• Iterative pharmacophore modeling was employed to design potential Akt pathway inhibitors.
• Energy-based calculations and property predictions guided the selection of candidate compounds.
• In vitro assays were performed to assess the inhibitory effects on Akt phosphorylation and cancer cell proliferation.

Main Results:

• Three novel compounds demonstrated variable inhibitory effects on Akt phosphorylation.
• These compounds also exhibited differential impacts on the proliferation of human neoplastic cells.
• One lead compound exhibited potent inhibition of both human carcinoma cell proliferation and Akt activation.

Conclusions:

• The identified lead compound shows significant potential as an Akt pathway inhibitor for cancer treatment.
• Targeted inhibition of the PI3K/Akt pathway is a viable therapeutic approach for human cancers.
• Further investigation of this lead compound is warranted for its clinical development.